Acetylsalicylic acid resistance risk factors in patients with myocardial infarction

Background despite its commonly recognized benefits in the cardiovascular disease setting,an issue of resistance to this drug has lately emerged. the aim of this research was assessment of the phenomenon of acetylsalicylic acid (asa) resistance and its risk factors in patients treated for myocardial infarction. methods this study is a post-hoc analysis of a previous prospective study with approximately 200 patients treated for myocardial infarction with a coated formulation of asa. the population was divided into two subgroups according to the response to asa. asa responsiveness was assessed using the arachidonic acid-dependent platelet aggregation (aspi-test). the measurements were performed using the technique of impedance aggregometry. results the prevalence of aspirin resistance among the study population was 6.2%. all analyzed aggregometric parameters (including aspi-test,adenosine diphosphate dependent platelet aggregation - adp-test,bleeding time measurement) showed significant differences between both subgroups. asa resistant patients had higher concentrations of brain natriuretic peptide (bnp),high-sensitivity c-reactive protein (hs-crp),leukocytes (wbc) and platelets (plt) but lower concentrations of hemoglobin (hgb). the temporal point analysis for both subgroups showed aspirin resistance incidence peak in patients at 9 months after myocardial infarction. conclusions the prevalence of aspirin resistance in our study population is comparable with rates reported in literature among patients with cardiovascular diseases. there is a possible relation between aspirin resistance and clopidogrel resistance. presence did not affect the incidence of the clinical end-points. © 2015 institute of pharmacology,polish academy of sciences.